Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study

The aim of the study was to evaluate the activity of Raphamin in a model of non-lethal pneumococcal infection caused byStreptococcus pneumoniae 3 in BALB/c mice. The drug or placebo was administered intragastrically 3 days prior to infection, 2 h before and 2 h post infection, and then for 3 full days, alone or in combination with antibiotic (amoxicil-lin/clavulanic acid). Raphamin monotherapy significantly decreased bacterial load in the lungs in comparison with placebo (p<0.05) which was comparable to the effect in antibiotic alone or combined with Raphamin. Raphamin prevented reproduction ofStreptococcus pneumoniae in the lower respiratory tract and its combination with the antibiotic was safe and did not reduce the efficacy of amoxicillin/clavulanic acid.
Source: Bulletin of Experimental Biology and Medicine - Category: Biology Source Type: research